CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

On June 4, 2024, an op-ed I penned (Project 2025’s threat to democracy) was published in The Fulcrum, a national bipartisan ...

All statements, other than statements of historical facts, contained in this press release are forward-looking statements, including express or implied statements regarding Fulcrum’s Phase 1b ...

Fulcrum Health earns its sixth Press Ganey Award, which recognizes care systems that consistently deliver exceptional patient experiences PLYMOUTH, Mass., Feb. 5, 2025 /PRNewswire-PRWeb/ -- Fulcrum ...

On June 4, 2024, an op-ed I penned (Project 2025’s threat to democracy) was published in The Fulcrum, a national non-partisan ...

CAMBRIDGE, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company ...